ArticleDiscover oncology2023

Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma.

Hewen Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.